U.S. Biotech Stock News

Federated Hermes (FHI) drew attention after posting improved quarterly results, with both revenue and net income increasing from last year. Management also highlighted growth in money market and equity strategies, as well as international momentum. See our latest analysis for Federated Hermes. The latest results add to a string of positive developments for Federated Hermes, including a recently affirmed dividend and progress on leadership succession. The momentum is showing in the numbers:...

In the past week, Flex and LG Electronics announced a partnership to develop integrated modular cooling solutions for AI data centers, while Flex also revealed ongoing collaborations with NVIDIA and expanded its data center infrastructure operations in North America and Europe. These moves highlight Flex's commitment to addressing rapid growth in high-performance computing and position the company as a key supplier amid surging demand for scalable, energy-efficient data center...

MDU Resources Group announced third quarter 2025 results in the past week, reporting US$315.1 million in sales and raising its full-year earnings guidance to a range of US$0.90 to US$0.95 per share, citing strong pipeline segment performance and new regulatory approvals. Notably, the company gained regulatory approval to invest in the Badger Wind Farm and reported record profits in its pipeline segment, reflecting expanded capacity and increased customer demand. We will now consider how this...

L3Harris Technologies announced its third quarter and nine-month results, showing increases in sales, net income, and earnings per share compared to a year ago. These numbers could be catching the eye of investors. See our latest analysis for L3Harris Technologies. L3Harris Technologies' recent earnings beat and successful share buyback program have coincided with positive momentum in its share price, now at $290.66. The stock’s 40.2% year-to-date share price return signals fresh investor...

Omnicell (OMCL) just delivered its third quarter earnings, raised its full-year revenue guidance, and announced further progress on its share buyback program. These moves offer clear and material signals for investors considering the stock. See our latest analysis for Omnicell. After a challenging start to the year, Omnicell’s 1-month share price return of 20% shows clear momentum following the earnings beat, higher revenue guidance, and progress on its buyback. Still, the 1-year total...

HF Sinclair (DINO) just delivered a big turnaround in its third-quarter earnings, swinging to a profit and growing its sales over last year. Alongside the results, the company is taking steps to expand its refined products infrastructure across the western US. The goal is to address changing market dynamics and set up for long-term growth. See our latest analysis for HF Sinclair. Investors have taken notice of HF Sinclair’s turnaround, with the share price climbing over 26% in the last three...

Kite Realty Group Trust recently reported third quarter 2025 results, raised its quarterly dividend by 7.4% year-over-year, and announced the completion of a US$74.94 million share buyback program. This combination of financial updates, capital return, and share repurchases points to the company’s focus on shareholder returns and financial strength. We'll explore how the recently announced dividend increase informs the current investment narrative for Kite Realty Group Trust. Trump has...

IDEAYA Biosciences reported strong third-quarter results, posting US$207.83 million in revenue and a net income of US$119.24 million, marking a turnaround from a net loss one year ago. This shift to profitability, highlighted by improved per-share earnings, has drawn continued positive commentary from major Wall Street analysts. We'll examine how IDEAYA Biosciences' newfound profitability sharpens its investment narrative for investors interested in oncology and precision medicine. Trump has...

In recent weeks, Alkami Technology announced that Jeanne D'Arc Credit Union has adopted its full Digital Sales & Service Platform, integrating MANTL's Onboarding & Account Opening Solution to streamline member experiences and accelerate digital transformation across multiple banking channels. This move highlights Alkami’s growing traction in the financial services sector, coinciding with expanded client relationships and a leadership transition as Cassandra Hudson assumes the CFO role. Next,...

On November 6, 2025, News Corp reported financial results for the first quarter ended September 30, posting revenue of US$2.14 billion and net income of US$112 million, both slightly above the prior year and outperforming analyst expectations. An interesting development was management's decision to accelerate share repurchases, citing strong digital segment growth and a robust cash position, which points to increased confidence in the company's outlook. Against this backdrop of...

Structure Therapeutics Inc. recently reported a third quarter 2025 net loss of US$65.71 million, up from US$33.98 million a year earlier, and highlighted advancing milestones in its oral obesity drug pipeline including upcoming clinical data readouts and the expansion of its amylin receptor agonist program. This combination of deepening financial losses and significant pipeline progress has been accompanied by ongoing analyst confidence in the company’s long-term research strategy. We'll...

In late October 2025, Simpson Manufacturing Co., Inc. released its third quarter 10-Q, completed new facilities in Ohio and Tennessee, updated its 2025 financial guidance (projecting a 19.0% to 20.0% consolidated operating margin), announced a US$150 million share repurchase program, and declared a quarterly dividend of US$0.29 per share payable in January 2026. The company's recent facility expansions and continued cost-saving initiatives underscore an emphasis on operational efficiency and...

In November 2025, EVERTEC, Inc. reported third quarter sales of US$228.59 million and net income of US$32.86 million, both rising over the same period last year, and raised its full-year 2025 revenue and earnings guidance, expecting revenue between US$921 million and US$927 million as well as higher earnings per share targets. The company's upgraded outlook and continued positive financial performance highlight ongoing operational momentum and growing confidence in demand across its digital...

Vertex Pharmaceuticals (VRTX) shares have been moving in a fairly tight range recently, leaving investors wondering what the next catalyst might be. Despite subdued short-term returns, the company’s longer-term growth trends help frame the outlook for its stock. See our latest analysis for Vertex Pharmaceuticals. After a steady climb earlier this year, Vertex Pharmaceuticals' share price has recently pulled back, reflecting a pause in momentum even as the company continues to report healthy...

In late October 2025, Welltower Inc. completed a US$5.26 billion follow-on equity offering, announced a broad executive leadership realignment, reported higher revenue for the third quarter, and reaffirmed its quarterly dividend, but also lowered its annual earnings guidance for 2025. Recent promotions and technology-focused hires reflect Welltower's increased emphasis on operational efficiency and digital transformation as it accelerates its shift towards senior housing within its...

Teekay Tankers Ltd. recently reported third-quarter 2025 earnings, revealing revenue of US$229.02 million and net income of US$92.08 million, with earnings per share notably higher than the previous year; a US$0.25 per share cash dividend was also announced for the quarter. The company’s strong net income despite lower revenue underscores robust operational performance and effective cost management amid shifting market conditions. We'll examine how Teekay Tankers' stronger-than-expected...

Innodata (INOD) shares have attracted attention following recent moves in the data solutions space. Over the past month, the stock has experienced shifts in value. This has prompted investors to take a closer look at what might be driving the action. See our latest analysis for Innodata. While this month hasn’t been smooth sailing for Innodata, with a 21.83% drop in the 30-day share price return, the stock still shows major staying power. It has posted a 62.47% gain over the past 90 days and...

Zoetis, Inc. reported its third quarter earnings along with a revenue guidance update for 2025, giving investors a transparent view of operational stability. The company’s recent product approval in Europe further underscores its focus on innovation. See our latest analysis for Zoetis. While Zoetis delivered year-over-year growth in both revenue and net income, plus expanded its European product lineup, recent share price momentum tells a different story. The stock closed at $120.24 after a...

Ellington Financial Inc. recently reported strong third quarter 2025 results, posting net income of US$36.58 million and achieving earnings per share of US$0.29, with revenue growth notably outpacing market expectations. A noteworthy aspect of this performance was the company’s increased long-term financing through securitizations and unsecured notes, enhancing its balance sheet stability and supporting future earnings resilience. We’ll explore how the company's expanded long-term,...

Zscaler (ZS) just rolled out fresh enhancements to its Zscaler Digital Experience platform, with a clear focus on tackling digital downtime and network performance headaches. The new features are designed to improve real-time monitoring and streamline issue detection across complex enterprise environments. See our latest analysis for Zscaler. It’s been an eventful year for Zscaler, with momentum clearly on the rise. After some recent product-driven buzz, the company’s share price has climbed...

Natera (NTRA) just raised its earnings and revenue outlook for 2025, increasing guidance by $160 million at the midpoint. The company’s new targets come as gross margin strength and ongoing cost momentum continue to drive performance. See our latest analysis for Natera. It’s been an active stretch for Natera, with expanded guidance, solid quarterly results, and new product milestones all contributing to improved sentiment. The latest share price stands at $199.57, up 17.9% over the past...

Wondering if Veracyte is offering real value right now? You're not alone, and with so much movement in health tech stocks, this could be a good moment to take a closer look. Veracyte shares have rallied recently, jumping 15.6% in the last week and up 19.8% for the past month, easily outpacing the broader market. The buzz isn't just about the price. A series of positive research collaborations and analyst upgrades are turning heads, giving fresh context to the recent...

Marvell Technology (MRVL) shares have drifted a bit recently, slipping 3% over the past week but still holding onto a 6% gain for the month. The movement has some investors re-examining whether recent momentum is starting to fade. See our latest analysis for Marvell Technology. Zooming out, Marvell Technology’s share price has pulled back from recent highs. While momentum over the past month was positive, its year-to-date loss and modest one-year total shareholder return of -2.8% suggest...

Affiliated Managers Group announced in early November that it reported strong third-quarter earnings, with net income rising to US$212.4 million, and continued its share buyback program, repurchasing 334,572 shares for US$76.97 million during the quarter. An interesting detail is that AMG’s third-quarter earnings per share from continuing operations dramatically increased year-over-year, while the company remains active in both paying dividends and reducing outstanding shares through...